PR Newswire/Les Echos/
AbbVie Files Form 8-K
NORTH CHICAGO, ILLINOIS, U.S.A., May 10, 2013 - AbbVie Inc. ("AbbVie") (NYSE /
CHX / Euronext Paris / SIX: ABBV) today informs its stockholders that it has
filed a Current Report on Form 8-K with the U.S. Securities and Exchange
Commission ("SEC") disclosing the future retirement of AbbVie's Senior Vice
President, Chief Scientific Officer, stockholder approval of the AbbVie 2013
Incentive Stock Program, and the results of voting at the 2013 Annual
AbbVie makes available free of charge on its website, its Annual Report on Form
10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, reports
filed pursuant to Section 16 of the U.S. Securities Exchange Act of 1934 and
amendments to those reports filed with or furnished to the SEC as soon as
reasonably practicable after AbbVie electronically files these documents with,
or furnishes them to, the SEC. These documents are posted on AbbVie's website
The SEC maintains a website that contains reports, proxy statements and other
information regarding issuers that file electronically with the SEC. These
materials may be obtained electronically by accessing the SEC's home page at
Copies of the above referenced information will also be made available, free of
charge, upon written request to AbbVie Inc., Investors Relations, 1 North
Waukegan Road, North Chicago, Illinois 60064, U.S.A.
SOURCE AbbVie Inc.
The content and accuracy of news releases published on this site and/or
distributed by PR Newswire or its partners are the sole responsibility of the
originating company or organisation. Whilst every effort is made to ensure the
accuracy of our services, such releases are not actively monitored or reviewed
by PR Newswire or its partners and under no circumstances shall PR Newswire or
its partners be liable for any loss or damage resulting from the use of such
information. All information should be checked prior to publication.
-0- May/13/2013 07:31 GMT
Press spacebar to pause and continue. Press esc to stop.